Legend Biotech Corp (LEGN) — Capital Reinvestment Ratio
Latest as of September 2025:
0.17x
Legend Biotech Corp (LEGN) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow ($28.80 Million) in capital expenditures ($5.00 Million). See Legend Biotech Corp (LEGN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
$28.80 Million
USD
Capital Expenditures
$5.00 Million
USD
Data as of
Sep 2025
Most recent filing
Legend Biotech Corp Capital Reinvestment Ratio (2018–2018)
This chart tracks Legend Biotech Corp's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Legend Biotech Corp (2018–2018)
Year-by-year Capital Reinvestment Ratio for Legend Biotech Corp from 2018 to 2018. For live market cap and broader valuation context, see Legend Biotech Corp (LEGN) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.07x | $307.68 Million | $21.02 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow